Georgetown University

Mike Pishvaian is a gastrointestinal oncologist, Co-Director of the Pancreatic Cancer Program at the Reusch Center, and head of the Phase I Program at the Lombardi Comprehensive Cancer Center.  Dr. Pishvaian is an MD and a PhD in Tumor Biology, and earned both degrees at Georgetown in 2001.  He has been at Georgetown since graduating, completing his medical residency in 2004, then his fellowship in Hematology/Oncology in 2007. 

Dr. Pishvaian is a translational oncologist, focused on providing novel therapy for patients, particularly in the areas of pancreatic cancer, and refractory colorectal cancer.  Dr. Pishvaian is the Principal Investigator of numerous Phase I and Phase II clinical trials.  In particular, he is the National lead in several multi-institutional trials in pancreatic cancer, and recently received an AACR-PanCAN Research Acceleration Network award to lead a clinical trial of molecularly tailored therapy for patients with metastatic pancreatic cancer.